1) Maintain a firm commitment to science-based, data-driven decision-making

2) Shield the agency’s science and its scientific staff from political influence

3) Facilitate the free flow of scientific and technical information

4) Protect the integrity of scientific data and ensuring its accurate 
    presentation, including the underlying assumptions and uncertainties

5) Require a fair and transparent approach to resolving internal scientific
     disputes, including hearing and carefully considering differing views

6) Support whistleblower protections

7) Select and promote scientists based on their knowledge, expertise
     and integrity

8) Use peer review of data and research used in decision-making,
     where feasible, appropriate and consistent with the law

9) Maintain openness and selecting qualified advisory committee members
     based on expertise, with transparency about conflicts of interest

10) Allow FDA staff to communicate their personal scientific or policy views
       to the public, even when those views differ from official Agency opinions

 
11) Promote the professional development of our scientists by encouraging publication
      in and editorial service to peer reviewed journals, presentations at professional
      meetings, and full participation in appropriate professional or scholarly societies
      and related activities that may benefit the public health